![James Anthony Wigginton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Anthony Wigginton
Directeur/Membre du Conseil chez ATF Group (PDF) Ltd.
Profil
James Anthony Wigginton is currently a Director at ATF Group (PDF) Ltd.
He was previously an Independent Non-Executive Director at ViaGold Rare Earth Resources Holdings Ltd.
from 1998 to 2014.
He was also a Director at Evivar Medical Pty Ltd.
Postes actifs de James Anthony Wigginton
Sociétés | Poste | Début |
---|---|---|
ATF Group (PDF) Ltd.
![]() ATF Group (PDF) Ltd. Financial ConglomeratesFinance Part of The Australian Technology Fund Pty Ltd., ATF Group (PDF) Ltd. offers tax management services to remove the time and stress of managing tax affairs for businesses. The Australian company provides specialized expertise and advice in taxation, accounting, BAS agent, tax returns, and company setup. Additionally, they offer meeting room rental and services related to accounting, bookkeeping, business accounting, tax accounting, finance, and SMSF. The company's tax returns are done efficiently and are easy to understand. | Directeur/Membre du Conseil | - |
Anciens postes connus de James Anthony Wigginton
Sociétés | Poste | Fin |
---|---|---|
VIAGOLD RARE EARTH RESOURCES HOLDINGS LIMITED | Directeur/Membre du Conseil | 20/06/2014 |
Evivar Medical Pty Ltd.
![]() Evivar Medical Pty Ltd. Medical/Nursing ServicesHealth Services Evivar Medical is a joint venture company established in February 2006 to provide accurate and timely Hepatitis B therapy management through its SeqHepB system - a web-based decision support tool to assist physicians to optimise and individualise the treatment schedule of patients with chronic hepatitis B. The SeqHepB system can be used to identify HBV mutations present in the patient and to determine resistance levels to the various available antiviral therapies. SeqHepB is a unique viral genomics sequence analysis program that is linked to a HBV genomic database. Evivar Medical joint venture partners are Melbourne Health (including the Victorian Infectious Diseases Reference Laboratory [VIDRL]), Melbourne Health Collaborative Consortium Partners (including leading clinicians from Australia, the Netherlands, Germany and Spain) and the ATF Group (PDF) Limited. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
ViaGold Rare Earth Resources Holdings Ltd.
![]() ViaGold Rare Earth Resources Holdings Ltd. Finance/Rental/LeasingFinance ViaGold Rare Earth Resources Holdings Ltd. is an investment holding company, which engages in the process and production of rare earth, education management and leasing activities. It operates through the following segments: Rare Earth Refining and Separation; Leasing and Capital Financing; and Provision of Consultancy and Management Services to Educate Institutions. The company was founded on August 18, 1995 and is headquartered in Zhuhai, China. | Finance |
ATF Group (PDF) Ltd.
![]() ATF Group (PDF) Ltd. Financial ConglomeratesFinance Part of The Australian Technology Fund Pty Ltd., ATF Group (PDF) Ltd. offers tax management services to remove the time and stress of managing tax affairs for businesses. The Australian company provides specialized expertise and advice in taxation, accounting, BAS agent, tax returns, and company setup. Additionally, they offer meeting room rental and services related to accounting, bookkeeping, business accounting, tax accounting, finance, and SMSF. The company's tax returns are done efficiently and are easy to understand. | Finance |
Evivar Medical Pty Ltd.
![]() Evivar Medical Pty Ltd. Medical/Nursing ServicesHealth Services Evivar Medical is a joint venture company established in February 2006 to provide accurate and timely Hepatitis B therapy management through its SeqHepB system - a web-based decision support tool to assist physicians to optimise and individualise the treatment schedule of patients with chronic hepatitis B. The SeqHepB system can be used to identify HBV mutations present in the patient and to determine resistance levels to the various available antiviral therapies. SeqHepB is a unique viral genomics sequence analysis program that is linked to a HBV genomic database. Evivar Medical joint venture partners are Melbourne Health (including the Victorian Infectious Diseases Reference Laboratory [VIDRL]), Melbourne Health Collaborative Consortium Partners (including leading clinicians from Australia, the Netherlands, Germany and Spain) and the ATF Group (PDF) Limited. | Health Services |